News

This article looks into progressive loss of neurons in the brain, which is one of the main processes in dementia and age-related cognitive impairment. This can be detected with current biomarker tests.

An exciting new stage is iminent for the patients who wish to continue after completing the ELAD trial of the anti-diabetic drug, liraglutide, in patients with Alzheimer’s disease.

Several trials have investigated the use of anti-amyloid therapies in Alzheimer’s disease, but these have all had disappointing results.

Here at Imperial College London we are always looking for more volunteers for all of our studies. We are in particular need of healthy volunteers for all of our trials.

Diabetes and Alzheimer’s disease are both very common conditions in the UK’s elderly. In the last 20 years a link has been suggested between these diseases.

This study has looked into the resident immune cells in the brain and when they are present in the brain. It is thought that these are initially protecting the neurons and repair damage to them, however as the disease progresses they become damaging and trigger more inflammation in the brain.